Literature DB >> 7999261

Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C beta and eta mRNAs in the tumors.

S Doi1, D Goldstein, H Hug, I B Weinstein.   

Abstract

Previous studies have suggested that protein kinase C (PKC) may play an important role in colon carcinogenesis and that human colon tumors have less total PKC enzyme activity than normal tissue. Because PKC is a multigene family that encodes for at least 11 distinct isoforms, in the study reported here we analyzed the expression of six of these isoforms at the mRNA level by northern blot hybridization in 22 pairs of primary colon tumors (of various stages), and adjacent normal mucosa samples. We found that the normal mucosa samples expressed the mRNAs of the following isoforms of PKC, in decreasing order of abundance: PKC delta > PKC eta > PKC alpha > PKC beta > PKC epsilon. There was no consistent difference in the levels of PKC alpha, PKC delta, and PKC epsilon mRNAs between the normal mucosa and the tumor samples. PKC gamma was expressed at a very low level in two of the colon tumors but could not be detected in the remaining tumors or any of the normal mucosa samples. The levels of both PKC beta and PKC eta mRNAs were significantly lower in the tumor samples than in the normal mucosa samples, and this was true of adenomas as well as Dukes' stage A, B, and C adenocarcinomas. Furthermore, the decrease in PKC eta mRNA appeared to be greater in the more poorly differentiated carcinomas. This finding is of interest because PKC eta is normally expressed in the more differentiated cells of epithelial tissues. The decreased levels of both PKC beta and PKC eta mRNAs occurred early in the multistage process of colon carcinogenesis, as it was also seen in adenomas. The functional significance of these changes remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999261     DOI: 10.1002/mc.2940110405

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  6 in total

1.  Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.

Authors:  Flavia A Wald; Andrea S Oriolo; Anastasia Mashukova; Nevis L Fregien; Amber H Langshaw; Pedro J I Salas
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

2.  Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions between PKC inhibitors and UGT1A6.

Authors:  L P Volak; M H Court
Journal:  Xenobiotica       Date:  2010-05       Impact factor: 1.908

3.  Phosphorylated extracellular signal-regulated protein kinases 1 and 2 phosphorylate Sp1 on serine 59 and regulate cellular senescence via transcription of p21Sdi1/Cip1/Waf1.

Authors:  Hong Seok Kim; In Kyoung Lim
Journal:  J Biol Chem       Date:  2009-03-24       Impact factor: 5.157

4.  The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.

Authors:  Elisabeth Ersvaer; Astrid Olsnes Kittang; Peter Hampson; Kristoffer Sand; Bjørn Tore Gjertsen; Janet M Lord; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2010-01-22       Impact factor: 4.546

5.  Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs.

Authors:  Divya Ram Jayaram; Sigal Frost; Chanan Argov; Vijayasteltar Belsamma Liju; Nikhil Ponnoor Anto; Amitha Muraleedharan; Assaf Ben-Ari; Rose Sinay; Ilan Smoly; Ofra Novoplansky; Noah Isakov; Debra Toiber; Chen Keasar; Moshe Elkabets; Esti Yeger-Lotem; Etta Livneh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-30       Impact factor: 11.205

6.  Protein kinase C Inhibitors selectively modulate dynamics of cell adhesion molecules and cell death in human colon cancer cells.

Authors:  Muzaffer Dükel; Zehra Tavsan; Duygu Erdogan; Deniz Erkan Gök; Hulya Ayar Kayali
Journal:  Cell Adh Migr       Date:  2018-10-11       Impact factor: 3.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.